Using lymphocyte count to predict CAR-T cell therapy efficacy in relapsed multiple myeloma

WCM Myeloma Center posted on X:

“New research led by Drs. Mateo Mejia, Ruben Niesvizky and Mark Bustoros showed that a simple blood test may help predict whether patients with relapsed Multiple Myeloma will respond to chimeric antigen (CAR) T-cell therapy.”